PRIME MEDICINE INC
(NASDAQ: PRME)
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
6.735
+0.075
(+1.13%)
Range
6.620 - 7.130
(7.70%)
Open
-
Previous Close
6.660
Bid Price
13.880
Bid Volume
10
Ask Price
14.390
Ask Volume
12
Volume
536,223
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis